Gastric Motility Disorder Drug Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281348 No. of Pages: 71 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Gastric Motility Disorder Drug in global, including the following market information:
Global Gastric Motility Disorder Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gastric Motility Disorder Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Gastric Motility Disorder Drug companies in 2021 (%)
The global Gastric Motility Disorder Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Velusetrag Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastric Motility Disorder Drug include Theravance, Inc., Helsinn Healthcare S.A., Concert Pharmaceuticals, Inc., Targacept, Inc. and ChironWells GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastric Motility Disorder Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastric Motility Disorder Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gastric Motility Disorder Drug Market Segment Percentages, by Type, 2021 (%)
Velusetrag
Ipamorelin
TD-8954
Others
Global Gastric Motility Disorder Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gastric Motility Disorder Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Home Use
Global Gastric Motility Disorder Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gastric Motility Disorder Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastric Motility Disorder Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gastric Motility Disorder Drug revenues share in global market, 2021 (%)
Key companies Gastric Motility Disorder Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Gastric Motility Disorder Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Theravance, Inc.
Helsinn Healthcare S.A.
Concert Pharmaceuticals, Inc.
Targacept, Inc.
ChironWells GmbH
1 Introduction to Research & Analysis Reports
1.1 Gastric Motility Disorder Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastric Motility Disorder Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastric Motility Disorder Drug Overall Market Size
2.1 Global Gastric Motility Disorder Drug Market Size: 2021 VS 2028
2.2 Global Gastric Motility Disorder Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Gastric Motility Disorder Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Gastric Motility Disorder Drug Players in Global Market
3.2 Top Global Gastric Motility Disorder Drug Companies Ranked by Revenue
3.3 Global Gastric Motility Disorder Drug Revenue by Companies
3.4 Global Gastric Motility Disorder Drug Sales by Companies
3.5 Global Gastric Motility Disorder Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Gastric Motility Disorder Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Gastric Motility Disorder Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastric Motility Disorder Drug Players in Global Market
3.8.1 List of Global Tier 1 Gastric Motility Disorder Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastric Motility Disorder Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastric Motility Disorder Drug Market Size Markets, 2021 & 2028
4.1.2 Velusetrag
4.1.3 Ipamorelin
4.1.4 TD-8954
4.1.5 Others
4.2 By Type - Global Gastric Motility Disorder Drug Revenue & Forecasts
4.2.1 By Type - Global Gastric Motility Disorder Drug Revenue, 2017-2022
4.2.2 By Type - Global Gastric Motility Disorder Drug Revenue, 2023-2028
4.2.3 By Type - Global Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Gastric Motility Disorder Drug Sales & Forecasts
4.3.1 By Type - Global Gastric Motility Disorder Drug Sales, 2017-2022
4.3.2 By Type - Global Gastric Motility Disorder Drug Sales, 2023-2028
4.3.3 By Type - Global Gastric Motility Disorder Drug Sales Market Share, 2017-2028
4.4 By Type - Global Gastric Motility Disorder Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Gastric Motility Disorder Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Home Use
5.2 By Application - Global Gastric Motility Disorder Drug Revenue & Forecasts
5.2.1 By Application - Global Gastric Motility Disorder Drug Revenue, 2017-2022
5.2.2 By Application - Global Gastric Motility Disorder Drug Revenue, 2023-2028
5.2.3 By Application - Global Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Gastric Motility Disorder Drug Sales & Forecasts
5.3.1 By Application - Global Gastric Motility Disorder Drug Sales, 2017-2022
5.3.2 By Application - Global Gastric Motility Disorder Drug Sales, 2023-2028
5.3.3 By Application - Global Gastric Motility Disorder Drug Sales Market Share, 2017-2028
5.4 By Application - Global Gastric Motility Disorder Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Gastric Motility Disorder Drug Market Size, 2021 & 2028
6.2 By Region - Global Gastric Motility Disorder Drug Revenue & Forecasts
6.2.1 By Region - Global Gastric Motility Disorder Drug Revenue, 2017-2022
6.2.2 By Region - Global Gastric Motility Disorder Drug Revenue, 2023-2028
6.2.3 By Region - Global Gastric Motility Disorder Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Gastric Motility Disorder Drug Sales & Forecasts
6.3.1 By Region - Global Gastric Motility Disorder Drug Sales, 2017-2022
6.3.2 By Region - Global Gastric Motility Disorder Drug Sales, 2023-2028
6.3.3 By Region - Global Gastric Motility Disorder Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Gastric Motility Disorder Drug Revenue, 2017-2028
6.4.2 By Country - North America Gastric Motility Disorder Drug Sales, 2017-2028
6.4.3 US Gastric Motility Disorder Drug Market Size, 2017-2028
6.4.4 Canada Gastric Motility Disorder Drug Market Size, 2017-2028
6.4.5 Mexico Gastric Motility Disorder Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Gastric Motility Disorder Drug Revenue, 2017-2028
6.5.2 By Country - Europe Gastric Motility Disorder Drug Sales, 2017-2028
6.5.3 Germany Gastric Motility Disorder Drug Market Size, 2017-2028
6.5.4 France Gastric Motility Disorder Drug Market Size, 2017-2028
6.5.5 U.K. Gastric Motility Disorder Drug Market Size, 2017-2028
6.5.6 Italy Gastric Motility Disorder Drug Market Size, 2017-2028
6.5.7 Russia Gastric Motility Disorder Drug Market Size, 2017-2028
6.5.8 Nordic Countries Gastric Motility Disorder Drug Market Size, 2017-2028
6.5.9 Benelux Gastric Motility Disorder Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Gastric Motility Disorder Drug Revenue, 2017-2028
6.6.2 By Region - Asia Gastric Motility Disorder Drug Sales, 2017-2028
6.6.3 China Gastric Motility Disorder Drug Market Size, 2017-2028
6.6.4 Japan Gastric Motility Disorder Drug Market Size, 2017-2028
6.6.5 South Korea Gastric Motility Disorder Drug Market Size, 2017-2028
6.6.6 Southeast Asia Gastric Motility Disorder Drug Market Size, 2017-2028
6.6.7 India Gastric Motility Disorder Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Gastric Motility Disorder Drug Revenue, 2017-2028
6.7.2 By Country - South America Gastric Motility Disorder Drug Sales, 2017-2028
6.7.3 Brazil Gastric Motility Disorder Drug Market Size, 2017-2028
6.7.4 Argentina Gastric Motility Disorder Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastric Motility Disorder Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Gastric Motility Disorder Drug Sales, 2017-2028
6.8.3 Turkey Gastric Motility Disorder Drug Market Size, 2017-2028
6.8.4 Israel Gastric Motility Disorder Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Gastric Motility Disorder Drug Market Size, 2017-2028
6.8.6 UAE Gastric Motility Disorder Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Theravance, Inc.
7.1.1 Theravance, Inc. Corporate Summary
7.1.2 Theravance, Inc. Business Overview
7.1.3 Theravance, Inc. Gastric Motility Disorder Drug Major Product Offerings
7.1.4 Theravance, Inc. Gastric Motility Disorder Drug Sales and Revenue in Global (2017-2022)
7.1.5 Theravance, Inc. Key News
7.2 Helsinn Healthcare S.A.
7.2.1 Helsinn Healthcare S.A. Corporate Summary
7.2.2 Helsinn Healthcare S.A. Business Overview
7.2.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Major Product Offerings
7.2.4 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales and Revenue in Global (2017-2022)
7.2.5 Helsinn Healthcare S.A. Key News
7.3 Concert Pharmaceuticals, Inc.
7.3.1 Concert Pharmaceuticals, Inc. Corporate Summary
7.3.2 Concert Pharmaceuticals, Inc. Business Overview
7.3.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Major Product Offerings
7.3.4 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales and Revenue in Global (2017-2022)
7.3.5 Concert Pharmaceuticals, Inc. Key News
7.4 Targacept, Inc.
7.4.1 Targacept, Inc. Corporate Summary
7.4.2 Targacept, Inc. Business Overview
7.4.3 Targacept, Inc. Gastric Motility Disorder Drug Major Product Offerings
7.4.4 Targacept, Inc. Gastric Motility Disorder Drug Sales and Revenue in Global (2017-2022)
7.4.5 Targacept, Inc. Key News
7.5 ChironWells GmbH
7.5.1 ChironWells GmbH Corporate Summary
7.5.2 ChironWells GmbH Business Overview
7.5.3 ChironWells GmbH Gastric Motility Disorder Drug Major Product Offerings
7.5.4 ChironWells GmbH Gastric Motility Disorder Drug Sales and Revenue in Global (2017-2022)
7.5.5 ChironWells GmbH Key News
8 Global Gastric Motility Disorder Drug Production Capacity, Analysis
8.1 Global Gastric Motility Disorder Drug Production Capacity, 2017-2028
8.2 Gastric Motility Disorder Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastric Motility Disorder Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastric Motility Disorder Drug Supply Chain Analysis
10.1 Gastric Motility Disorder Drug Industry Value Chain
10.2 Gastric Motility Disorder Drug Upstream Market
10.3 Gastric Motility Disorder Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastric Motility Disorder Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com